F. García-Pajares

ORCID: 0000-0002-3354-5280
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Organ Transplantation Techniques and Outcomes
  • Gallbladder and Bile Duct Disorders
  • Pediatric Hepatobiliary Diseases and Treatments
  • Hepatitis C virus research
  • Renal Transplantation Outcomes and Treatments
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pancreatitis Pathology and Treatment
  • Esophageal and GI Pathology
  • Liver Diseases and Immunity
  • Transplantation: Methods and Outcomes
  • Biliary and Gastrointestinal Fistulas
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Vascular Anomalies and Treatments
  • Liver physiology and pathology
  • Tracheal and airway disorders
  • Drug-Induced Adverse Reactions
  • Pancreatic and Hepatic Oncology Research
  • Neonatal Health and Biochemistry
  • Hepatitis B Virus Studies
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • Cardiac and Coronary Surgery Techniques
  • Parvovirus B19 Infection Studies

Hospital Universitario Río Hortega
2014-2025

Universidad de Valladolid
2010

Massachusetts General Hospital
2008

Harvard University
2008

Background/Objectives: Data on the natural history and endoscopic treatment outcomes of recurrent anastomotic biliary stricture (RABS) after orthotopic liver transplantation (OLT) are limited. This study aimed to evaluate incidence RABS OLT. Methods: A retrospective single-center OLT patients who underwent successful ABS was conducted. The RABS, risk factors for recurrence, repeat therapy were recorded. Results: total 131 with treatment, which 119 successfully completed an course. After a...

10.3390/jcm14072198 article EN Journal of Clinical Medicine 2025-03-24

of stones.Traditionally, it was considered a fatal disease almost exclusively critical ill patients; however, there are recent reports cases AAC affecting less severe patients with good prognosis treated antibiotics, in the absence cholecystectomy.We herein report case young man who developed after Salmonella enteritidis gastrointestinal infection. CASE REPORTA 27-year-old admitted to hospital abdominal pain, diarrhoea, persistent vomiting and 38℃ temperature.On physical examination, he...

10.3748/wjg.14.6408 article EN cc-by-nc World Journal of Gastroenterology 2008-01-01

Abstract Background & Aims (i) To describe the demographic, clinical, virological and histological characteristics of patients undergoing evaluation for indication triple therapy against hepatitis C virus genotype 1, to identify reasons why candidate are excluded; (ii) evaluate healthcare environment related treatment. Methods Observational, prospective multi‐centred study involving 16 hospitals Spain. Data were collected on 1122 receiving attention in outpatient clinics between June...

10.1111/liv.12536 article EN Liver International 2014-03-20

The role of systemic immunity in the pathogenesis cirrhosis is not fully understood. Analysis transcriptomic profiles blood an easy approach to obtain a wide picture immune response at level. We studied gene expression from thirty cirrhotic patients and compared them against those eight healthy volunteers. Most our were male [n = 21, 70%] their middle ages [57.4 ± 6.8 yr]. Alcohol abuse was most frequent cause (n 22, 73%). Eleven had hepatocellular carcinoma (36.7%). Eight suffered hepatitis...

10.1371/journal.pone.0137128 article EN cc-by PLoS ONE 2015-08-28

Obesity is considered a risk factor for perioperative complications, but its effect on patients undergoing liver transplantation (LT) remains unclear. This study was conducted to analyze the impact of obesity early morbidity and mortality following LT.A multicenter outcomes in submitted LT between 2009 2019 conducted. Recipients were stratified into obese (BMI ≥ 30 kg/m2) nonobese < kg/m2). Early postoperative complications compared 30-day 1-year patient graft survival assessed by...

10.1097/meg.0000000000002574 article EN European Journal of Gastroenterology & Hepatology 2023-05-22

Spain is worldwide leader in deceased donation rates per million habitants and count on a strong network of twenty-five liver transplant institutions. Although the access to transplantation higher than other countries, approximately 10% patients qualifying for will die waiting list or would be excluded due clinical deterioration. A robust prioritization system paramount grant sickest with first positions an earlier transplant. In addition, allocation policy may not create perpetuate...

10.17235/reed.2024.10639/2024 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2024-01-01

Background and aims: Nonalcoholic fatty liver disease (NAFLD) is a long-term complication after transplantation. Our aims were to determine de-novo-NAFLD at 5-year post-liver transplantation identify predictive risk factors. Methods: This was retrospective analysis of NAFLD defined as the radiological evidence steatosis. Data from transplanted patients between November 2001 May 2014 collected. Noninvasive fibrosis scores calculated. Predictors de-novo survival assessed by multivariate...

10.1097/meg.0000000000001736 article EN European Journal of Gastroenterology & Hepatology 2020-04-10

INTRODUCCIÓNA pesar de que en la actualidad poseemos conocimientos más profundos sobre fisiopatología pancreatitis aguda (PA), y disponemos mejores medios terapéuticos fundamentalmente a nivel cuidados intensivos, sin embargo se mantiene una elevada morbili- Interleucina-18 (IL-18) otros parámetros inmunológicos como

10.4321/s1130-01082008001200006 article ES publisher-specific-oa Revista Española de Enfermedades Digestivas 2008-12-01

The graft versus host disease after liver transplant is rare, with an incidence less than 1%, but a high mortality (75-85%), especially due to infectious complications. It usually affects gastrointestinal tract, skin and blood system in the context of normal function. There no consensus on most appropriate treatment: some articles support reduction or even elimination immunosuppressive drugs, while others published success dose increase.We report case 68 year-old recipient retrieved from ABO...

10.17235/reed.2015.3722/2015 article EN publisher-specific-oa Revista Española de Enfermedades Digestivas 2015-01-01

The evidence suggests that most vulnerable subjects to COVID-19 infection suffer from patients with comorbidities or immunosuppression, including liver transplant recipients. Liver graft dysfunction may be a rare complication. Some complain about the post-COVID-19 syndrome. aim of this study was assess medium- and short-term outcomes in patients.A retrospective case series performed at tertiary referral center. We screened 845 who had (LT) our All consecutive LT during Spanish outbreak March...

10.1016/j.jceh.2021.05.009 article EN other-oa Journal of Clinical and Experimental Hepatology 2021-05-31
Coming Soon ...